The therapeutic potential of targeting tryptophan catabolism in cancer

Based on its effects on both tumour cell intrinsic malignant properties as well as anti-tumour immune responses, tryptophan catabolism has emerged as an important metabolic regulator of cancer progression. Three enzymes, indoleamine-2,3-dioxygenase 1 and 2 (IDO1/2) and tryptophan-2,3-dioxygenase (TD...

Descripción completa

Detalles Bibliográficos
Autores principales: Opitz, Christiane A., Somarribas Patterson, Luis F., Mohapatra, Soumya R., Dewi, Dyah L., Sadik, Ahmed, Platten, Michael, Trump, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964670/
https://www.ncbi.nlm.nih.gov/pubmed/31819194
http://dx.doi.org/10.1038/s41416-019-0664-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964670/
https://www.ncbi.nlm.nih.gov/pubmed/31819194
http://dx.doi.org/10.1038/s41416-019-0664-6

Ejemplares similares